Market
Highlights
In
thumb arthritis, the cushion-like cartilage inside the CMC joint breaks down,
causing the bones to rub against each other. Increasing prevalence of thumb
arthritis, growing geriatric and obese population, and rising healthcare
expenditure are some of the major factors estimated to drive the market growth
during the forecast period. A study was published in the HAND (American
Association for Hand Surgery) journal in 2016, according to which the
prevalence of the thumb CMC osteoarthritis was estimated to be around 8%-12% in
the general population. However, the high cost of the surgical therapeutics
along with related complications is estimated to restrain the market growth
during the forecast period.
The
Global Thumb Arthritis Market is expected to grow at an approximate CAGR of
8.1% during the forecast period.
Segmentation
The
global thumb arthritis market is segmented on the basis of type, diagnosis,
treatment, and end user. On the basis of the type, the market is segmented into
osteoarthritis thumb arthritis, rheumatoid thumb arthritis, and others. On the
basis of the diagnosis, the market is segmented into physical examinations,
imaging, fine needle aspiration (FNA), and others. The imaging segment is
sub-segmented into X-ray, computed tomography (CT), magnetic resonance imaging
(MRI), and others.
On
the basis of the treatment, the market is segmented into thumb exercise,
medication, surgery, and others. The medication segment is sub-segmented into
OCT medications, prescription medications, and others. The surgery segment is
sub-segmented into trapeziectomy, osteotomy, and others.
On
the basis of the end users, the market is segmented into hospitals &
clinics, research organizations, retail pharmacies, and others.
Regional
Analysis
The
Americas dominate the global thumb arthritis market. A well-developed
healthcare sector, growing geriatric population, and increasing healthcare
expenditure are the major drivers for the growth of the global thumb arthritis
market.
Europe
holds the second largest thumb arthritis market owing to the availability of
the funds for research, increasing surgery adoption rates, and growing patient
population. According to the Office for National Statistics the geriatric
population within the region is expected to grow and reach 20.5% of the total
U.K population by 2026 from 18.0% in 2016.
Asia
Pacific is the fastest growing region. Growing geriatric and obese population
followed by the developing healthcare sector are boosting the market growth.
Within the region, Australia holds a significant ratio of the obese population.
However, the presence of the developing economies like India and China are
marked by expanding healthcare sector. This is estimated to provide favorable
backgrounds for the market growth.
The
Middle East and Africa region account for the least market share. This is
mainly due to the presence of the poor African economies within the region,
which have low per capita income and lack of the medical services. On the
other, the Middle East holds the largest market share within the region.
Key
Players
The key players in the global thumb arthritis
market are inclusive of BioPro (U.S.), McKie Splints (U.S.), AbbVie Inc.
(U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Amgen Inc. (U.S.), Pfizer Inc.
(U.S.), Carestream Health. (U.S.), General Electric Company (U.K), and others.
No comments:
Post a Comment